Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales39 87421 84820 24720 74921 96923 307
Operating income (EBITDA)12 6164 9745 8624 4125 6916 149
Operating profit (EBIT)9 8334 0464 3143 9964 4654 795
Pre-Tax Profit (EBT)6 2632 521----
Net income5 9632 5762 2843 0073 0523 381
EPS ( $)3,721,621,491,962,082,33
Dividend per Share ( $)1,670,640,900,951,031,12
Yield3,46%1,32%1,86%1,97%2,13%2,31%
Announcement Date01/23/2013
12:47pm
01/22/2014
12:44pm
01/29/2015
12:45pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt9 6743 0863 7821 0401 5211 155
Finance------
Operating income (EBITDA)12 6164 9745 8624 4125 6916 149
Leverage
(Debt/EBITDA)
0,77x0,62x0,65x0,24x0,27x0,19x
Capital Expenditure1 7951 1451 0771 1351 2221 258
Book Value Per Share (BVPS)17,0 $16,3 $14,3 $17,6 $18,9 $20,2 $
Cash Flow per Share5,85 $2,11 $2,41 $3,36 $3,21 $3,61 $
Announcement Date01/23/2013
12:47pm
01/22/2014
12:44pm
01/29/2015
12:45pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 72 914 M$ -
Entreprise Value (EV) 73 954 M$ 74 435 M$
Valuation 2015e 2016e
PER (Price / EPS) 24,7x 23,2x
Capitalization / Revenue 3,51x 3,32x
EV / Revenue 3,56x 3,39x
EV / EBITDA 16,8x 13,1x
Yield (DPS / Price) 1,97% 2,13%
Price to book (Price / BVPS) 2,74x 2,56x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 19,3% 20,3%
operating Leverage (Delta EBIT / Delta Sales) - 2,00x
Net Margin (Net Profit / Revenue) 14,5% 13,9%
ROA (Net Profit / Asset) 7,23% 7,82%
ROE (Net Profit / Equities) 13,6% 13,8%
Rate of Dividend 48,7% 49,4%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   5,47% 5,56%
Cash Flow / Sales (Taux d'autofinancement) 24,4% 22,0%
Capital Intensity (Assets / Sales) 2,00x 1,78x
Financial Leverage (Net Debt / EBITDA) 0,24x 0,27x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF